Reaching the targets for tuberculosis control: the impact of HIV

被引:20
作者
Laserson, K. F. [1 ]
Wells, C. D. [1 ]
机构
[1] Ctr Dis Control & Prevent, KEMRI, Kisumu, Kenya
关键词
D O I
10.2471/BLT.06.035329
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In 1991, the 44th World Health Assembly set two key targets for global tuberculosis (TB) control to be reached by 2000: 70% case detection of acid-fast bacilli smear-positive TB patients under the DOTS strategy recommended by WHO and 85% treatment success of those detected. This paper describes how TB control was scaled up to achieve these targets; it also considers the barriers encountered in reaching the targets, with a particular focus on how HIV infection affects TB control. Strong TB control will be facilitated by scaling-up WHO-recommended TB/HIV collaborative activities and by improving coordination between HIV and TB control programmes; in particular, to ensure control of drug-resistant TB. Required activities include more HIV counselling and testing of TB patients, greater use and acceptance of isoniazid as a preventive treatment in HIV-infected individuals, screening for active TB in HIV-care settings, and provision of universal access to antiretroviral treatment for all HIV-infected individuals eligible for such treatment. Integration of TB and HIV services in all facilities (i.e. in HIV-care settings and in TB clinics), especially at the periphery, is needed to effectively treat those infected with both diseases, to prolong their survival and to maximize limited human resources. Global TB targets can be met, particularly if there is renewed attention to TB/HIV collaborative activities combined with tremendous political commitment and will.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 32 条
[11]   The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model [J].
Dowdy, DW ;
Chaisson, RE ;
Moulton, LH ;
Dorman, SE .
AIDS, 2006, 20 (05) :751-762
[12]   Prospects for worldwide tuberculosis control under the WHO DOTS strategy [J].
Dye, C ;
Garnett, GP ;
Sleeman, A ;
Williams, BG .
LANCET, 1998, 352 (9144) :1886-1891
[13]  
GETAHUN H, IN PRESS LANCET
[14]  
GHANDI NR, 2006, LANCET
[15]   Increasing transparency in partnerships for health - introducing the Green Light Committee [J].
Gupta, R ;
Cegielski, JP ;
Espinal, MA ;
Henkens, M ;
Kim, JY ;
Lambregts-van Weezenbeek, CSB ;
Lee, JW ;
Raviglione, MC ;
Suarez, PG ;
Varaine, F .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2002, 7 (11) :970-976
[16]  
Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847
[17]   Managing HIV and tuberculosis in sub-Saharan Africa [J].
Harries, AD ;
Boxshall, M ;
Phiri, S ;
Kwanjana, J .
LANCET, 2006, 367 (9525) :1817-1818
[18]  
Harries AD, 2005, INT J TUBERC LUNG D, V9, P128
[19]   International standards for tuberculosis care [J].
Hopewell, Philip C. ;
Pai, Madhukar ;
Maher, Dermot ;
Uplekar, Mukund ;
Raviglione, Mario C. .
LANCET INFECTIOUS DISEASES, 2006, 6 (11) :710-725
[20]   Combining PMTCT with active case finding for tuberculosis [J].
Kali, Paida B. N. ;
Gray, Glenda E. ;
Violari, Avy ;
Chaisson, Richard E. ;
McIntyre, James A. ;
Martinson, Neil A. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (03) :379-381